Dangerous Drugs

Dangerous Drug Lawyers — Pharmaceutical Injury & Failure-to-Warn Claims

Prescription and over-the-counter medications cause serious injury every year despite FDA approval. Manufacturers conceal risks in clinical trials, misrepresent side effects in marketing, and fail to warn doctors and patients. Trial Lawyers United represents individuals harmed by dangerous drugs and holds pharmaceutical companies accountable.

Types of Dangerous Drug Claims

Pharmaceutical injury cases involve multiple legal theories and product categories:

• Prescription drugs: Medications requiring physician authorization (e.g., Depo-Provera, Roundup).
• Over-the-counter medications: Available without prescription; often assumed safe because available without physician oversight.
• Biologics: Injectable proteins including monoclonal antibodies and other engineered therapeutics.
• Supplements and herbs: Products marketed as natural and safe; may contain undisclosed active ingredients or contaminants.

Each category carries specific liability theories and evidence requirements.

Common Legal Claims in Dangerous Drug Litigation

Failure to warn of side effects

Manufacturers must disclose material risks associated with medications. When they fail to warn healthcare providers or patients, they are liable for injuries caused by unknown or inadequately warned risks. Warning failures include:

• Omission of known adverse effects from package inserts.
• Burying warnings in fine print; inadequate prominence given to serious risks.
• Failure to update warnings when new safety data emerges.

Off-label marketing

FDA approves drugs for specific indications (conditions). Manufacturers are prohibited from marketing drugs for uses not approved by the FDA. Off-label promotion occurs when:

• Sales representatives encourage prescribing for non-approved conditions.
• Marketing materials emphasize off-label uses.
• No warnings are provided for the risks specific to the off-label use.

Manufacturing contamination and quality defects

Drugs must be manufactured according to FDA-approved specifications. Contamination or deviation from specifications causes injury:

• Microbial contamination (bacterial, fungal).
• Chemical contamination (wrong active ingredients, impurities).
• Particulate matter and foreign objects.

Fraudulent concealment of trial data

Manufacturers conduct clinical trials to establish safety and efficacy. When companies:

• Falsify or manipulate trial data.
• Suppress adverse findings or safety signals.
• Submit misleading submissions to the FDA.
• They have committed fraud, and injured patients may recover punitive damages.

Regulatory Context: FDA Approval Does Not Prevent Liability

FDA approval is often misunderstood as a guarantee of safety. In reality:

• FDA approval evaluates the drug based on submitted data; fraud or concealment in submissions undermines the approval’s validity.
• Post-market surveillance: Adverse events continue to be reported after approval; manufacturers must monitor and update warnings.
• Regulatory approval does not shield manufacturers from liability for negligence, fraud, or failure to warn.
• State law product liability claims are not preempted by federal FDA approval.

How Dangerous Drug Cases Work

Successful dangerous drug litigation typically involves:

Discovery of internal documents

We request and obtain:

• Clinical trial data and reports.
• FDA submissions and correspondence.
• Safety and pharmacovigilance databases.
• Internal communications (emails, memos) showing knowledge of risks.
• Marketing materials and sales training documents.

Expert testimony

We retain:

• Pharmacologists and toxicologists: Establishing mechanism of drug-induced injury.
• Epidemiologists: Analyzing population-level risk and causation.
• Physicians in the relevant specialty: Establishing medical standards of care and causation in individual cases.
• Regulatory experts: Explaining what the manufacturer should have disclosed to the FDA and to physicians.

Adverse event databases

We analyze:

• FDA FAERS (Adverse Event Reporting System): Public database of adverse events; available to attorneys.
• Manufacturer-held databases: Requested during discovery; show real-world adverse events post-approval.
• Temporal patterns: Identifying when adverse events peaked or when manufacturer should have recognized a safety signal.

Current TLU Dockets in Dangerous Drug Litigation

Trial Lawyers United actively litigates in the following pharmaceutical injury areas:

• Depo-Provera (meningioma brain tumors)
• Roundup (non-Hodgkin’s lymphoma)
• Paraquat (Parkinson’s disease)

Frequently Asked Questions

The FDA approved this drug. How can it be dangerous?

FDA approval is based on data submitted by the manufacturer. If that data was falsified or concealed adverse findings, the approval’s validity is undermined. Additionally, new adverse events continue to emerge post-approval; manufacturers have a duty to warn of new risks.

My doctor prescribed this drug. Can I still sue the manufacturer?

Yes. Your doctor prescribed based on information provided by the manufacturer. If the manufacturer failed to warn your doctor of material risks, both the doctor and manufacturer may bear liability. We evaluate claims against both.

What if I knew about potential side effects but took the drug anyway?

If you took a drug knowing the risks, you may have accepted the risk. However, if the actual risk was substantially greater than disclosed, or if the drug caused a different injury than warned, you may still recover. We evaluate comparative fault and assumption of risk on a case-by-case basis.

How long do I have to file a claim?

Statute of limitations is state-specific and typically begins when you knew (or should have known) that your injury was caused by the drug. Many drug claims accrue over years as symptoms develop and causation becomes apparent. We ensure timely filing.